Macrovesicular steatosis in nonalcoholic fatty liver disease is a consequence of purine nucleotide cycle driven fumarate accumulation
M. C. Sinton, B. Lucendo Villarin, J. Meseguer Ripolles, S. Wernig-Zorc, J. P. Thomson, P. D. Walker, A. Thakker, G. G. Lavery, C. Ludwig, D. A. Tennant, D. C. Hay, A. J. Drake
Abstract
SummaryNonalcoholic fatty liver disease (NAFLD) affects ~88% of obese individuals and is characterised by hepatic lipid accumulation. Mitochondrial metabolic dysfunction is a feature of NAFLD. We used a human pluripotent stem cell-based system to determine how mitochondrial dysfunction is linked to hepatic lipid accumulation. We induced lipid accumulation in hepatocyte-like cells (HLCs) using lactate, pyruvate and octanoate (LPO). Transcriptomic analysis revealed perturbation of mitochondrial respiratory pathways in LPO exposed cells. Using 13C isotopic tracing, we identified truncation of the TCA cycle in steatotic HLCs. We show that increased purine nucleotide cycle (PNC) activity fuels fumarate accumulation and drives lipid accumulation in steatotic cells. These findings provide new insights into the pathogenesis of hepatic steatosis and may lead to an improved understanding of the metabolic and transcriptional rewiring associated with NAFLD.Competing Interest StatementProfessor David Hay is a founder, shareholder and director in Stemnovate Limited.View Full Text
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nonalcoholic fatty liver disease is associated with decreased hepatocyte mitochondrial respiration but not mitochondrial number
M. C. Sinton, J. Meseguer-Ripolles, … A. J. Drake·bioRxiv·Mar 10, 2020
- Mitochondrial Dysfunction Induces Hepatic Lipid Accumulation and Inflammatory Responses in mtDNA Mutator Mice
Jaime M. Ross, Angela Kim, … Giuseppe Coppotelli·bioRxiv·Apr 25, 2025
- Mtfp1 ablation enhances mitochondrial respiration and protects against hepatic steatosis
C. Patitucci, J. D. Hernandez Camacho, … T. Wai·bioRxiv·Apr 26, 2023
- Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function
G. Wolff, M. Sakurai, … S. Herzig·bioRxiv·Dec 17, 2021
- N-acetyl-phenylalanine induces hepatic steatosis in MASLD by disrupting ER-mitochondria calcium coupling and mitochondrial lipid oxidation
Rémy Lefebvre, Theo Rousseaux, … Cyrielle Caussy·bioRxiv·Sep 24, 2025
- Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA
Yo Han Lee, Hyun‐Jun Jang, … Jang Hyun Choi·eLifePeer-reviewed·Dec 29, 2021